Stock Movers Phillips, Shell Slump, Stellantis Cut
Jul 7, 2025
European medical tech stocks are feeling the pinch as China retaliates against EU restrictions, with firms like Philips remaining resilient. Meanwhile, Shell's shares dip after disappointing earnings forecasts, signaling a rare miss after years of growth. Stellantis sees a downgrade from Bank of America, citing concerns over their weak position in Europe despite a strong US market. These declines in key sectors raise questions about the broader economic impact.
AI Snips
Chapters
Transcript
Episode notes
China's EU Medical Tech Ban Impact
- European medical tech stocks fell after China barred EU companies from its government procurement for certain medical devices.
- Analysts see limited revenue impact due to strong local presence but acknowledge the sentiment hit.
Shell's Weak Quarter Hits Earnings
- Shell's shares sank over 3% due to a weaker second-quarter performance than expected.
- This marks their first earnings hit in years, driven by falling crude prices.
Stellantis Faces Competitive Challenges
- Bank of America downgraded Stellantis to neutral, forecasting a weak first half-year report.
- The automaker faces tough competition, especially from cheaper EVs from China, hurting European positioning.